Monoamine oxidase inhibitors (MAOI) are recognised to prolong and enhance the results of dimethyltryptamine (copyright) and a single review assumed that the effect on psilocybin would be related since it is a structural analogue of copyright.[145] Having said that, only a small portion of psilocin appears for being metabolized by https://therapeutic-psychedelics81368.sharebyblog.com/30428400/the-smart-trick-of-copyright-therapist-that-nobody-is-discussing